A service of StreetInsider.com
Ticker Symbol

Most Popular

AAPL 107.57
GOOG 769.41
MSFT 58.17
FB 123.89
BAC 15.53

Recently Added

MDM 4.94
ACBI 15.47
QHC 6.01
LOAN 5.89
BEBE 0.83

Gaining Speed

ACBI 15.47
MDM 4.94
VPIG 0.17
HCN 77.00
CPIX 4.65

ZIOPHARM Oncology (ZIOP) Reports Palifosfamide Hits PFS Events in Phase 3

ZIOPHARM Oncology, Inc. (Nasdaq: ZIOP) announced today that the Phase 3 (PICASSO 3) trial of palifosfamide (ZIO-201) in first-line metastatic soft tissue sarcoma has reached its target number of progression-free survival (PFS) events. PICASSO 3 is an international, randomized, double-blind, placebo-controlled trial whose primary endpoint is PFS....

Read More




Get Alerted When News Hits On This Stock - FREE!